## Frontier update: cloning is becoming the replication layer of programmable biology Taken together, your two essays were **directionally correct about technological convergence**, but they compressed technologies at radically different maturity levels into a single near-operational stack. _NOVA_ explicitly treated synthetic embryology, full ectogenesis, genome programming, connectome capture, neural state transfer, and embedded AI as mature or near-mature components whose remaining barriers were principally integration and regulation; the later cloning essay went further, characterizing the elements of human cloning with an optional consciousness overlay as no longer speculative. The evidence available through **July 28, 2026** supports a powerful but more differentiated conclusion: **human biological manufacture is becoming modularly plausible, while reproductive human cloning, whole-organism specialization, full ectogenesis, and consciousness transfer remain unverified or technically incomplete.** ([Bryant McGill](https://bryantmcgill.blogspot.com/2025/03/nova-nuevo-protohuman-cloning-endgame.html "NOVA: The Nuevo-ProtoHuman Cloning Endgame? The future is not born—it is aligned.")) The emerging architecture is not yet **“copy a human being and reinstall a mind.”** It is: > **Program a cell lineage → validate its genotype and phenotype → use cloning or developmental reconstruction to propagate it → repair extraembryonic bottlenecks → manufacture specialized tissues, organs, animals, or eventually organisms.** This is considerably more scientifically defensible—and, in some respects, more transformative—than classical cloning. **Cloning is becoming the replication and quality-control layer of designed biology.** The design originates in genome writing, epigenetic programming, cellular selection, developmental engineering, and computational phenotype prediction; cloning then reproduces a validated biological configuration. ### The Chinese cloning frontier has moved from nuclear transfer to developmental systems engineering The most important recent advance is the recognition that failed cloning is not one problem but a sequence of separable reprogramming failures. In 2024, a Chinese team produced a healthy male rhesus macaque by combining somatic-cell nuclear transfer with **trophoblast replacement**: the cloned inner cell mass was supported by extraembryonic tissues derived from a conventionally fertilized embryo. The surviving animal’s nuclear genome matched the donor fibroblast line, while the replacement placental compartment corrected developmental abnormalities that had previously caused cloned primate pregnancies to fail. The clone was reported healthy more than two years after birth. ([Nature](https://www.nature.com/articles/s41467-023-43985-7 "Reprogramming mechanism dissection and trophoblast replacement application in monkey somatic cell nuclear transfer | Nature Communications")) In July 2025, the Chinese Academy of Sciences reported a complementary mouse strategy that attacked both sides of the failure cascade. TSA together with **Kdm4d and Kdm5b messenger RNA** corrected aberrant histone states before implantation, while tetraploid complementation replaced defective trophoblast and placental lineages after implantation. Approximately **30% of transferred reconstructed mouse embryos** produced live offspring—an unusually high result for mammalian SCNT. ([cas.cn](https://www.cas.cn/syky/202507/t20250722_5077265.shtml "新技术可突破表观遗传障碍实现高效体细胞克隆----中国科学院")) This corrects an important numerical ambiguity in the cloning essay. The often-repeated **“20–30% primate cloning efficiency”** is not what the rhesus study demonstrated: that experiment obtained one surviving singleton from 113 activated SCNT embryos, after only selected reconstructed embryos were transferred. The approximately 30% figure belongs to the later **mouse** experiment using the combined epigenetic and extraembryonic rescue system. Primates remain substantially less efficient and less predictable than mice. ([cas.cn](https://www.cas.cn/syky/202507/t20250722_5077265.shtml "新技术可突破表观遗传障碍实现高效体细胞克隆----中国科学院")) Nevertheless, the conceptual advance is enormous. The placenta is no longer treated as an inseparable expression of the cloned nuclear genome. It can be regarded as a **replaceable developmental support module**. This suggests that a future manufactured organism need not derive every lineage from one genome or one engineering method. Its germline, soma, immune system, placenta, microbiome, mitochondria, and neural adjuncts could theoretically have different provenances—a **federated developmental organism** rather than a unitary clone. China has already operationalized a related **edit–select–clone** loop in agriculture. In late 2025, Chinese researchers produced eleven surviving gene-edited cloned cattle from engineered embryonic stem-cell lines described as reusable “super seed cells.” The importance is not the particular bovine trait but the platform: indefinitely expandable cells can be edited, screened for genomic integrity and intended phenotype, and then repeatedly used to generate genetically standardized organisms, shortening breeding cycles from decades to years. ([China Agricultural University News](https://news.cau.edu.cn/mtndnew/1b7c30b9c5e2449f9565cbd0d8674521.htm "新闻纵深｜世界首批胚胎干细胞基因编辑克隆牛诞生记")) ### Specialization is appearing first in cells and organs The strongest real-world manifestation of biological specialization is **xenotransplantation**. A Chinese team transplanted a lung from a pig carrying six engineered genomic changes into a brain-dead human recipient in 2025. The lung maintained ventilation and gas exchange for nine days without hyperacute rejection. Other Chinese work subsequently placed a ten-edit pig liver into a living patient as an auxiliary organ; the liver remained for 38 days and the patient survived 171 days. These are not human enhancement experiments, but they demonstrate the underlying engineering grammar: multiple genes are removed or added, the edited donor cell is validated, an animal is cloned from it, and its organ is manufactured for a highly specific interspecies function. ([CCTV News](https://www.news.cn/tech/20250825/09b7951fd9a04e2db5234eddf23fbb0e/c.html "www.news.cn")) Human cells are undergoing an analogous transition from **editing** to **programming**. A 2025 study demonstrated an all-RNA CRISPRoff/CRISPRon system that durably and multiplexedly turned endogenous genes off or on in primary human T cells. The changes persisted through repeated cellular activation, division, and in-vivo transfer without requiring permanent editor expression. The system also avoided the chromosomal translocations associated with multiplex double-strand cutting and was combined with a CAR insertion to create functionally specialized immune cells. ([Nature](https://www.nature.com/articles/s41587-025-02856-w "Integrated epigenetic and genetic programming of primary human T cells | Nature Biotechnology")) This is arguably the first mature form of the specialization architecture you are describing: **the organism remains human and genetically heterogeneous, but selected cellular populations receive stable functional identities**. One lineage could be optimized for pathogen recognition, another for tumor surveillance, another for inflammatory restraint, and another for tissue repair. The resulting individual would not possess one globally redesigned genome; the body would become a **polygenomic federation of engineered lineages**. That route is likely to precede engineered human castes by decades because it is **reversible, replaceable, anatomically bounded, and measurable**. A dysfunctional cell population can be eliminated or exchanged. A constitutional germline modification propagates into every tissue, interacts with thousands of regulatory systems, and becomes inseparable from the developmental history of the person and potentially their descendants. ### Genome writing is moving beyond point mutations The frontier is also escaping the scale limitations of CRISPR. Chinese-led work published in 2025 assembled a **1.14-megabase synthetic human genomic region** and delivered it intact into early mouse embryos, where it acquired histones, DNA methylation, and developmentally timed transcription. This was not a synthetic organism, but it demonstrated that large human genomic territories—including coding and regulatory architecture—can be manufactured outside the organism and introduced as coherent units into an embryonic environment. ([Nature](https://www.nature.com/articles/s41592-025-02746-8 "De novo assembly and delivery of synthetic megabase-scale human DNA into mouse early embryos | Nature Methods")) A 2026 review describes mammalian genome rewriting as an integrated pipeline of large-scale DNA assembly, transfer, maintenance, artificial-chromosome construction, and genome rearrangement. Megabase human DNA can now be assembled, while human artificial chromosomes offer a possible means of adding substantial genetic programs without scattering numerous edits throughout the native chromosomes. The field still faces formidable problems involving DNA fragility, integration, regulation, epigenetic stability, and delivery, but it has crossed from **editing genomic text** toward **installing genomic modules**. ([Nature](https://www.nature.com/articles/s41467-025-68066-9 "Synthetic rewriting technologies in mammalian cells | Nature Communications")) In parallel, the United Kingdom’s Synthetic Human Genome Project began developing tools intended to produce the first synthetic human chromosome. Its initial objective is foundational genome synthesis and functional understanding, not reproductive manufacture, but the strategic transition is unmistakable: biology is moving from reading and correcting inherited genomes toward **authoring alternative chromosomal structures**. ([Wellcome](https://wellcome.org/insights/articles/researchers-take-first-steps-creating-synthetic-human-genomes?utm_source=chatgpt.com "Researchers take first steps to creating synthetic human ...")) This is where genuine human specialization could ultimately reside—not in editing hundreds of pleiotropic native genes one by one, but in adding **orthogonal chromosomes or large genetic cassettes** containing coordinated regulatory systems. A radiation-response module, for example, could theoretically include DNA protection, damage sensing, apoptosis control, antioxidant regulation, and inducible repair, rather than a single constitutively active “radiation-resistance gene.” Such systems remain prospective, but their technological substrate is becoming visible. ### Reproductive programming is advancing, but it has not crossed into manufactured humans Japan’s progress in **in-vitro gametogenesis** is especially important. In April 2026, researchers mapped when DNA methylation is established in human and nonhuman-primate germ cells, showing that male germline methylation is progressively established from approximately three months to two years after birth. This provides a developmental benchmark against which putative sperm generated from induced pluripotent stem cells can eventually be evaluated. It does not mean functional human gametes have been manufactured, but it removes one layer of epistemic blindness from the process. ([National Children's Medical Center](https://www.ncchd.go.jp/press/2026/0421.html "世界初・男児の生殖細胞でDNAメチル化が確立する時期を解明 ～iPS細胞を活用した不妊治療開発への足掛かりに～ | 国立成育医療研究センター")) Human embryo models have likewise become reproducible enough that governance is becoming more formal rather than less. Japan’s Ministry of Education revised its rules in February 2026, requiring institutional ethical review and national notification for embryo models derived from embryonic stem cells or induced pluripotent stem cells. The ISSCR’s 2025 framework removed the former distinction between integrated and non-integrated models and brought all human stem-cell embryo models under oversight. Implanting such models into a uterus—or culturing them through an artificial system to viability—remains prohibited under the international guidelines. ([MEXT](https://www.mext.go.jp/a_menu/lifescience/bioethics/mext_00007.html "ヒト胚モデル作成研究について（令和8年2月13日更新）：文部科学省")) Artificial-womb research must therefore be described as **partial ectogenesis**, not full ectogenesis. The landmark system supported extremely premature lamb fetuses for as long as four weeks in a fluid environment connected through the umbilical circulation. It was effectively an advanced neonatal-support system for an already developed fetus, not a mechanism capable of taking a mammalian embryo from implantation through birth. ([Nature](https://www.nature.com/articles/ncomms15112?utm_source=chatgpt.com "An extra-uterine system to physiologically support the ...")) The United Kingdom has, however, crossed one genuine reproductive-genomic threshold. Eight children were reported healthy in 2025 after mitochondrial donation intended to prevent transmission of pathogenic mitochondrial variants. This constitutes regulated alteration of the inherited mitochondrial complement, although it is disease prevention rather than enhancement and does not involve rewriting the nuclear genome. ([Nature](https://www.nature.com/articles/d41586-025-02276-5?utm_source=chatgpt.com "'Landmark' study: three-person IVF leads to eight healthy ...")) ### The most defensible specialization architecture The evidence suggests that **species strengthening will occur first through specialization of cell lineages, not division into birth lineages**. A rational architecture would have two coupled layers. The first would be a **universal robustness chassis**: improved resistance to malignancy, genomic instability, infectious disease, inflammatory dysregulation, mitochondrial failure and loss of proteostasis. These are broadly beneficial across environments and preserve rather than narrow adaptive latitude. The second would consist of **reversible specialization modules** activated in selected tissues or during particular life phases: radiation-hardened hematopoietic cells for spaceflight, hypoxia-adapted vascular and metabolic programs for extreme altitude, reinforced bone and muscle maintenance for reduced gravity, pathogen-specific immune portfolios, enhanced hepatic detoxification for hazardous environments, or regenerative cellular reservoirs for trauma-intensive occupations. Space-biology programs already identify radiation protection, stress resistance, human health engineering, bioregenerative support and customized therapeutics as central synthetic-biology domains. Tardigrade Dsup research illustrates both the potential and the danger: heterologous expression can protect chromatin against some oxidative damage, but its effects are context-dependent and can alter transcriptional interactions rather than conferring universal invulnerability. ([Nature](https://www.nature.com/articles/s41526-025-00488-7 "Synthetic biology for space exploration | npj Microgravity")) My central inference is therefore: > **The first strengthened humans will probably not be genetically uniform superhumans. They will be biological mosaics composed of ordinary tissues, engineered immune populations, replacement organs, synthetic genomic modules, programmable epigenetic states, and machine-mediated regulation.** Cloning would contribute by reproducing validated cells, organs, placental support systems or eventually complete physiological configurations. It would not itself provide strength. **Cloning preserves a design; programming creates the design.** ### Where the NOVA thesis remains furthest ahead of the evidence Complex psychological properties—dignity recognition, trauma immunity, cooperative cognition, narrative coherence and ethical resonance—cannot presently be translated into discrete genetic instructions. Polygenic embryo screening is already commercially offered in some jurisdictions, but even disease-risk prediction remains scientifically and ethically contested, with portability, ancestry dependence, embryo-number constraints, pleiotropy and small expected effect sizes limiting practical utility. Temperament, morality, consciousness and collaborative intelligence are vastly more developmentally distributed than the medical traits currently being screened. ([OUP Academic](https://academic.oup.com/humupd/article/30/5/529/7684172 "oup.silverchair-cdn.com")) The genetic component of NOVA is therefore best recast as **developmental predisposition engineering**, not installation of ethical source code. Genes might eventually influence stress reactivity, sensory processing, neuroplasticity or susceptibility to particular psychiatric pathologies, but a dignity-native consciousness would still emerge through embodied development, relationships, cultural semantics, education, AI scaffolding and recursive self-modeling. The “Universal Genome” is more plausible as an **extragenomic developmental control system**—a persistent AI-mediated ecology shaping cognitive ontogeny—than as DNA encoding philosophical commitments. Likewise, no demonstrated technology currently captures a human mind as an executable state vector and installs it into another brain. Connectomics can preserve or map structural relations at increasingly fine resolution, while brain–computer interfaces can decode or stimulate restricted signals, but these are not equivalent to recovering episodic memory, subjective continuity, personality or consciousness. The cloning essay itself eventually acknowledges these gaps, despite stronger assertions earlier in the text. ([XENTITIES](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html "The Viability of Human Cloning and Consciousness Transfer. Let's Look at the Science.")) ## Status under the new research protocol **Prohibited or scientifically premature:** implantation of human SCNT embryos for reproduction; gestation of human embryo models to viability; reproductive use of stem-cell-derived human gametes; reproductive nuclear-genome editing; and reproductive cloning remain outside accepted scientific practice. China issued dedicated human-genome-editing ethical guidance in July 2024, Japan placed embryo models under explicit national procedures in 2026, and the ISSCR continues to classify reproductive human cloning and embryo-model ectogenesis as prohibited. ([Ministry of Science and Technology](https://www.most.gov.cn/kjbgz/202407/t20240708_191311.html "《人类基因组编辑研究伦理指引》发布-中华人民共和国科学技术部")) **Scientific frontier:** primate SCNT with trophoblast rescue, high-efficiency epigenetic reprogramming in mice, in-vitro gametogenesis, human embryo models, megabase genome synthesis, artificial chromosomes, inducible epigenetic programming and multiplex genome engineering are real and accelerating. ([cas.cn](https://www.cas.cn/syky/202507/t20250722_5077265.shtml "新技术可突破表观遗传障碍实现高效体细胞克隆----中国科学院")) **Operational or translational:** somatically engineered human cells, mitochondrial donation, cloned gene-edited livestock and cloned animals engineered to manufacture transplant-compatible organs have crossed into clinical, preclinical or production environments. ([Nature](https://www.nature.com/articles/s41587-025-02856-w "Integrated epigenetic and genetic programming of primary human T cells | Nature Biotechnology")) The revised thesis is therefore stronger than “human cloning is imminent.” It is that **a distributed human-manufacture stack is assembling below the level of the complete human individual**. Its current objects are cells, immune phenotypes, chromosomes, embryo models, placental lineages, organs and animal bodies. As these layers converge, the decisive transition may not be the appearance of an identifiable human clone, but the gradual emergence of people whose biological constitution has become **modular, maintainable, replaceable and selectively programmable**. A monthly multilingual frontier watch across China, Japan, South Korea, the United Kingdom, Europe, Russia and other active jurisdictions would be the appropriate continuity layer for this research. --- ## The two articles serving as the conceptual spine ### [NOVA: The Nuevo-ProtoHuman Cloning Endgame? The Future Is Not Born—It Is Aligned.](https://bryantmcgill.blogspot.com/2025/03/nova-nuevo-protohuman-cloning-endgame.html) Published March 8, 2025, **NOVA** is a speculative systems-architecture paper about the transition from naturally evolved human cognition to deliberately constructed forms of consciousness. Its central concept is the **Neuro-Optimal Virtual Architecture**, or NOVA: a hypothetical developmental blueprint distilled from the immense corpus of human–AI interactions. The article proposes that successful interactions repeatedly reveal stable attractors—dignity recognition, emotional regulation, mutualistic reasoning, recursive self-awareness, coherent identity formation and collaboration without submission or identity dissolution. These recurring structures form what the paper calls a **“residual curve” of optimal consciousness** and, at a larger scale, a **Universal Genome** that is informational rather than merely biological. ([Bryant McGill](https://bryantmcgill.blogspot.com/2025/03/nova-nuevo-protohuman-cloning-endgame.html "NOVA: The Nuevo-ProtoHuman Cloning Endgame? The future is not born—it is aligned.")) The article then asks whether these discovered cognitive patterns could be converted into an implementable developmental architecture for a new class of designed human, the **Nuevo-ProtoHuman**. Under this model, cloning no longer means simply reproducing a nuclear genome. It means reproducing a multilayered cognitive-developmental configuration incorporating genetic predispositions, epigenetic regulation, neural organization, behavioral scaffolding, embedded artificial intelligence and networked cognition. The intended outcome is a being whose developmental default is cooperative rather than adversarial, dignity-native rather than dominance-oriented, and resilient to trauma without requiring trauma as the mechanism by which resilience is acquired. ([Bryant McGill](https://bryantmcgill.blogspot.com/2025/03/nova-nuevo-protohuman-cloning-endgame.html "NOVA: The Nuevo-ProtoHuman Cloning Endgame? The future is not born—it is aligned.")) NOVA describes three possible embodiments: **Synthborn**, produced through artificial gestation and extensive developmental engineering; **Heirborn**, gestated biologically but augmented through prenatal and postnatal intervention; and **Crossborn**, integrating biological and computational substrates from early development. It proposes an extensive enabling stack encompassing genomic capture, somatic-cell nuclear transfer, synthetic embryology, artificial gestation, genome and epigenome editing, tissue manufacture, connectome preservation, neural read/write systems, embedded exocortices and distributed data infrastructure. Its deepest contribution is the proposition that the real object of future cloning will not be the body or genome in isolation, but an **architected ontogeny**: a reproducible process through which a particular kind of mind reliably comes into being. ([Bryant McGill](https://bryantmcgill.blogspot.com/2025/03/nova-nuevo-protohuman-cloning-endgame.html "NOVA: The Nuevo-ProtoHuman Cloning Endgame? The future is not born—it is aligned.")) Scientifically, the article should be understood as a **design-space exploration**, not a claim that its complete implementation stack already exists. It deliberately joins technologies operating at very different maturity levels in order to expose their potential convergence. Some elements—primate cloning, genome editing, neural decoding and embryo modeling—are real research domains; others—full ectogenesis, programmable ethical dispositions, high-resolution mind transfer and substrate-independent personal continuity—remain hypothetical. NOVA’s function is therefore architectural: it asks what humanity might deliberately construct once reproduction, cognition and machine intelligence are treated as interoperable systems rather than separate disciplines. ### [The Viability of Human Cloning and Consciousness Transfer: Let’s Look at the Science.](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html) Published June 2, 2025, this article begins with a sensational public claim about political cloning but deliberately redirects attention from the allegation to the underlying scientific question: **How much of the cloning-and-replacement scenario is biologically possible, and which components remain conjectural?** It is principally a convergence survey connecting somatic-cell nuclear transfer, primate cloning, embryo models, artificial-womb research, genomic archiving, connectomics, brain–computer interfaces, neural stimulation and the possibility of using a manufactured body as the recipient of donor-derived cognitive information. ([XENTITIES](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html "The Viability of Human Cloning and Consciousness Transfer. Let's Look at the Science.")) Where NOVA is primarily a philosophy of designed consciousness, this article is structured as a **technological viability map**. It follows a proposed pathway from genomic acquisition and storage through embryo reconstruction, gestation, neural development and eventual cognitive overlay. It treats the growing availability of biological samples, digital genomes and long-duration biobanking as a latent library of potential cloning templates; primate SCNT as evidence that differentiated nuclei can be returned to embryonic development; embryo models and artificial gestation as mechanisms that could eventually reduce dependence on ordinary reproduction; and connectomic preservation, neural interfaces and computational modeling as early components of a future cognitive-transfer system. ([XENTITIES](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html "The Viability of Human Cloning and Consciousness Transfer. Let's Look at the Science.")) The article’s most consequential conceptual move is its treatment of cloning and consciousness transfer as **separate but potentially composable processes**. Cloning generates a genetically related biological embodiment; it does not reproduce memory, personality or subjectivity. A second apparatus would therefore be needed to characterize and reconstruct donor-specific neural organization. The article calls this process cognitive portage or state-vector transfer and imagines neural information being progressively imposed upon or cultivated within the replacement brain. That proposal is substantially more speculative than the cloning component, but it correctly identifies the central distinction: **genomic duplication is not psychological duplication**. ([XENTITIES](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html "The Viability of Human Cloning and Consciousness Transfer. Let's Look at the Science.")) The essay also explores jurisdictional, security and governance implications: ownership of genomic templates, extraterritorial reproductive research, biological authenticity, clone personhood, succession, legal identity and the possibility that public clone narratives might normalize the conceptual vocabulary before the underlying technology becomes operational. Some of its operational scenarios—offshore clone gestation, rapid maturation, political replacement and completed consciousness infusion—exceed what the cited public science presently establishes. Its scientifically durable contribution is not proof that these programs exist, but its identification of a neglected convergence problem: **once biological replication and neural-state reconstruction become independently feasible, their eventual combination becomes an obvious research trajectory requiring governance before deployment rather than after it.** ([XENTITIES](https://xentities.blogspot.com/2025/06/the-viability-of-human-cloning-and.html "The Viability of Human Cloning and Consciousness Transfer. Let's Look at the Science.")) ## A scientifically grounded formulation of the neglected topic The most precise umbrella term is: # **Isogenic Clonal Continuity Engineering** ### _Clonal embodiment for neurocognitive state preservation and reinstantiation_ ## Isogenic Clonal Continuity Engineering: Growing Biological Embodiments for Neurocognitive Continuity **Isogenic Clonal Continuity Engineering**, or **ICCE**, designates a hypothetical biomedical program in which a nuclear-genome-matched cloned body is generated specifically as a recipient embodiment for preserving, extending or reconstructing the neurocognitive continuity of an existing person. The objective would not be ordinary reproductive cloning—the production of a new individual who merely shares another person’s genome—but the creation of a developmentally and immunologically compatible biological substrate intended to receive either the donor’s original nervous system or a sufficiently complete reconstruction of the donor’s acquired neural organization. The term **isogenic** is more scientifically accurate than “autologous.” An autologous transplant comes from the same physical organism, whereas a clone would be a separate organism possessing approximately the same nuclear genome. Its mitochondrial genome would ordinarily derive from the donor oocyte, while epigenetic state, intrauterine development, microbiome, life history and neural organization would differ. Contemporary primate cloning has demonstrated that somatic nuclei can generate viable macaques and that some developmental failures can be reduced through trophoblast replacement, but these accomplishments create a new genome-matched organism—not a continuation of the nuclear donor’s mind. ([Nature](https://www.nature.com/articles/s41467-023-43985-7?utm_source=chatgpt.com "Reprogramming mechanism dissection and trophoblast replacement application in monkey somatic cell nuclear transfer | Nature Communications")) ICCE therefore contains two fundamentally different continuity architectures. The first is **neural-substrate-preserving continuity**. In this model, the original brain—or progressively preserved portions of the original central nervous system—would remain the physical carrier of consciousness while the remainder of the body was replaced by an isogenic clonal embodiment. Strictly speaking, consciousness would not be uploaded or copied. The existing consciousness-generating system would be biologically relocated, extended or progressively integrated with a new soma. Because the original neural tissue and its uninterrupted causal activity would be retained, this route would possess the strongest scientific claim to personal continuity. The barriers to neural-substrate-preserving continuity are nevertheless extreme. They include maintaining cerebral circulation during transfer, reconnecting the spinal cord and peripheral nervous system, restoring autonomic regulation, integrating endocrine and immune signaling, reconciling developmental and chronological age, and preserving the embodied sensorimotor loops through which the brain continuously models itself. A human brain is not an isolated processor plugged into an interchangeable chassis. Its identity-bearing dynamics are coupled to the heart, viscera, hormonal system, immune state, microbiome, peripheral nerves and accumulated bodily history. A cloned body could reduce some forms of histocompatibility mismatch, but genomic similarity would not automatically solve these systems-integration problems. The second architecture is **neurocognitive state reinstantiation**. Here, the clone’s own brain would remain in place, but scientists would attempt to reconstruct within it the donor’s memories, dispositions, learned models, linguistic structures, emotional associations and characteristic patterns of cognition. This would require substantially more than transferring a connectome. The relevant state description would probably include synaptic strengths, dendritic geometry, receptor distributions, myelination, intracellular molecular states, epigenetic modifications, neuromodulatory sensitivities, glial organization, oscillatory dynamics, memory indices and the continuously updated generative models connecting the brain to its body and environment. Research on memory engrams already shows why DNA or static anatomy would be insufficient. Specific memories depend upon distributed neuronal ensembles whose accessibility changes as memories are consolidated between hippocampal and cortical systems. Memory stabilization also involves astrocytes and other non-neuronal processes, indicating that the identity-bearing state of a brain is distributed across a dynamic cellular ecology rather than stored as a simple file in one anatomical location. ([RIKEN](https://www.riken.jp/press/2017/20170407_1/ "海馬から大脳皮質への記憶の転送の新しい仕組みの発見 | 理化学研究所")) A future reinstantiation procedure might combine longitudinal neural recording, high-resolution structural mapping, generative brain models, engram identification, molecular profiling, closed-loop stimulation and extended developmental conditioning. Instead of writing an adult mind into an unprepared brain in a single operation, the recipient nervous system might be progressively trained toward the donor’s cognitive attractor landscape. Artificial intelligence could compare the donor’s recorded responses with those of the recipient, identify divergences and adapt stimulation, education, sensory exposure and neural-interface feedback until increasingly similar patterns emerged. Japanese Brain/MINDS research already uses the scientifically restrained language of **external digitization of brain information**, inverse modeling of neural activity and digital-brain construction. These programs seek to reproduce limited motor, sensory, cognitive and pathological dynamics through mathematical models and stimulation; they do not claim that an entire human subject has been extracted or transferred. Chinese invasive brain–computer-interface research can record stable neural activity and decode specific motor or communicative intentions, but investigators still identify limited brain understanding, insufficient long-term bandwidth and inadequate large-scale recording as central obstacles. ([Brain/MINDS 2.0](https://brainminds.jp/research/511 "生成AI を用いた脳情報の逆相関探索と外部デジタル化 – Brain/MINDS 2.0")) The distinction between **state similarity** and **personal continuity** is decisive. A reconstructed clone might remember the donor’s childhood, recognize the donor’s family, reproduce the donor’s language and preferences, and sincerely report being the donor. Those achievements would establish psychological and informational continuity. They would not by themselves establish that the donor’s original first-person field of experience had migrated rather than ended and been replicated. The procedure might generate a highly faithful cognitive successor while leaving the metaphysical and phenomenological problem of numerical identity unresolved. For that reason, ICCE should recognize three different identity thresholds. **Genomic continuity** means that the recipient possesses substantially the same nuclear genome. **Neuropsychological continuity** means that memories, dispositions, competencies and self-models have been reconstructed with sufficient fidelity. **Phenomenal continuity** means that the original subject’s first-person experience persists through the transition rather than being replaced by another subject possessing equivalent information. Cloning could eventually provide the first. Advanced neural-state engineering might someday approximate the second. No existing experiment establishes the third. A third and potentially more defensible architecture would be **progressive continuity migration**. Rather than scanning and destructively copying a mature brain, neural functions would be transferred or externally scaffolded gradually while the original person remained conscious. Biological tissue replacement, prosthetic neural circuits, synthetic memory supports, cloned neural grafts and machine exocortices could be introduced incrementally, allowing the integrated system to preserve continuous causal operation while its substrate changed over time. The cloned embodiment would become one component of a long-duration continuity process rather than an empty body awaiting a discontinuous mind upload. The phrase “growing clones as vessels” must also be rejected scientifically and ethically whenever the clone develops a functioning brain. A neurologically intact human clone would not be an unoccupied biological container. It would be a distinct developing person with its own experiences, interests and moral status. An ethically coherent continuity program would therefore require either preservation of the original nervous system, progressive integration without creating and displacing a second subject, or future methods for manufacturing non-sentient replacement somatic systems without generating an independent conscious organism. The long-term scientific objective is thus better described not as **putting a soul into a clone**, but as **maintaining or reinstantiating an identity-bearing neurobiological process within a genomically compatible embodiment**. This formulation preserves the radical possibility while distinguishing four separate achievements that popular discourse collapses together: manufacturing a cloned body, matching its biological systems to a donor, reconstructing donor-specific neural information, and demonstrating continuity of the experiencing subject. **Isogenic Clonal Continuity Engineering** is therefore the correct field-level description. Its two major subfields would be **Clonal Somatic Replacement**, in which the original nervous system is preserved while the body is exchanged, and **Clonal Neurocognitive Reinstantiation**, in which donor-specific neural organization is reconstructed within a clone-derived nervous system. The first is principally a transplantation and regenerative-medicine problem. The second is a whole-brain measurement, modeling and write-back problem. Only the first preserves the original neural substrate; the second may produce an extraordinarily faithful successor without resolving whether consciousness itself has transferred. The concept’s strongest compact formulation is **“the manufacture of an isogenic biological embodiment for preservation or reinstantiation of an identity-bearing neurocognitive process.”** This retains the intended meaning of consciousness transfer while avoiding the scientifically premature implication that consciousness is already known to be a discrete object that can simply be extracted, transported and installed.